Bristol-Myers Squibb (BMY) insider buying

Healthcare · Drug Manufacturers - General · Market cap $122.0B

14 open-market purchases of BMY by Bristol-Myers Squibb's executives and directors since June 2025, worth $0 in total, from SEC Form 4 filings.

The most recent: Ro Khanna bought — on February 5, 2026.

The biggest buyer over the period is Ro Khanna: 10 purchases, $0.

By year

YearPurchasesValue
20264$0
202510$0

Biggest buyers

InsiderBuysValue
Ro Khanna
10$0
Gilbert Ray Cisneros, Jr.
4$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Feb 5, 2026 Ro Khanna
0$59.43— —
Feb 5, 2026 Ro Khanna
0$59.43— —
Jan 23, 2026 Ro Khanna
0$54.61— —
Jan 23, 2026 Ro Khanna
0$54.61— —
Dec 19, 2025 Gilbert Ray Cisneros, Jr.
0$54.15— —
Dec 19, 2025 Gilbert Ray Cisneros, Jr.
0$54.15— —
Nov 12, 2025 Gilbert Ray Cisneros, Jr.
0$49.13— —
Nov 12, 2025 Gilbert Ray Cisneros, Jr.
0$49.13— —
Nov 3, 2025 Ro Khanna
0$45.96— —
Nov 3, 2025 Ro Khanna
0$45.96— —
Sep 5, 2025 Ro Khanna
0$47.08— —
Sep 5, 2025 Ro Khanna
0$47.08— —
Jun 23, 2025 Ro Khanna
0$46.97— —
Jun 23, 2025 Ro Khanna
0$46.97— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BMY.
Open BMY in Investingly

Questions

Are Bristol-Myers Squibb insiders buying the stock?

14 open-market purchases of BMY by Bristol-Myers Squibb's executives and directors since June 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on February 5, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Bristol-Myers Squibb's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.